Acamprosate Calcium 333 mg/1
acamprosate calcium enteric-coated · TABLET, DELAYED RELEASE · Mylan Pharmaceuticals Inc.
Acamprosate Calcium is a tablet, delayed release containing acamprosate calcium enteric-coated at 333 mg/1, taken oral. Manufactured by Mylan Pharmaceuticals Inc..
Key Facts
- Brand Name
- Acamprosate Calcium
- Generic Name
- acamprosate calcium enteric-coated
- NDC Code (Product)
0378-6333- Manufacturer
- Mylan Pharmaceuticals Inc.
- Strength
- 333 mg/1
- Dosage Form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA200142
- Marketing Start
- 09/24/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Acamprosate Calcium used for?
Acamprosate Calcium contains acamprosate calcium enteric-coated. It is a tablet, delayed release taken oral. Consult your doctor for specific uses.
Is Acamprosate Calcium a controlled substance?
Acamprosate Calcium is not classified as a controlled substance by the DEA.
What is the generic name for Acamprosate Calcium?
The generic name for Acamprosate Calcium is acamprosate calcium enteric-coated. There are no other listed brand versions of acamprosate calcium enteric-coated.
What is the NDC code for Acamprosate Calcium 333 mg/1?
The NDC (National Drug Code) for Acamprosate Calcium 333 mg/1 is 0378-6333, listed by Mylan Pharmaceuticals Inc..
Other Acamprosate Calcium Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)